Wrap up interview: Cre8™ - How innovative technology enhances PCI clinical outcome

Summary

Is there a real difference in DES today, especially when it comes to answering the unmet needs involved in the treatment of the diabetic patient? Can an innovative polymer-free DES with a unique AmphilimusTM formulation provide a higher level of safety and efficacy? Join R. Mohd Ali, Kuala Lumpur, Malaysia along with J. Tan, Singapore and P. Stella, The Netherlands as they discuss the latest data and positive results of the polymer-free DES Cre8TM – an emerging tool in the armamentarium of the interventional cardiologist.